Wetter, Germany

Holger Lübben

This inventor holds 1 USPTO granted patent and 3 EPO patents. Top assignee: Seqirus UK Limited. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Holger Lübben. Retrieved from https://idiyas.com/inventor/holger-lübben

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Holger Lübben: Innovator in Pharmaceutical Production

Introduction

Holger Lübben is a notable inventor based in Wetter, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the production of active ingredients for drugs and diagnostic agents.

Latest Patents

Holger Lübben holds a patent for "Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an MDCK cell suspension culture." This invention outlines a method for producing an active ingredient of a drug or diagnostic agent. The patent also describes a process for mixing the active ingredient with appropriate adjuvants, buffers, diluents, or drug carriers.

Career Highlights

Lübben is currently associated with Seqirus UK Limited, where he applies his expertise in pharmaceutical development. His work focuses on innovative methods that enhance the efficiency and effectiveness of drug production.

Collaborations

Throughout his career, Holger Lübben has collaborated with esteemed colleagues, including Jürgen Vorlop and Christian Frech. These partnerships have contributed to advancements in pharmaceutical technologies.

Conclusion

Holger Lübben's innovative work in pharmaceutical production exemplifies the impact of dedicated inventors in the healthcare industry. His contributions continue to influence the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…